Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Arianna Bedoya
Clinical Research Coordinator III
College of Medicine - Phoenix
Full Page
Overview
Research
More
Collaboration
(16)
Kenneth Knox
Mutual work: 1 Proposal
Collaboration Details
Denise Roe
Mutual work: 2 Proposals
Collaboration Details
Mrinalini Kala
Mutual work: 2 Proposals
Collaboration Details
Linda Garland
Mutual work: 2 Proposals
Collaboration Details
George Watts
Mutual work: 1 Proposal
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(7)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney F
Active
·
2024
·
$0 / $704.8K
·
External
cardiovascular health,
kidney function,
drug efficacy,
clinical trials,
diabetes management
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subje
Active
·
2023
·
$0 / $815K
·
External
clinical trial,
drug safety,
cardiovascular,
inflammation,
pharmacology
Conform Pivotal Study: An Evaluation of the Safety and Effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS) for Left Atrial Appendage Occlusion}
Active
·
2023
·
$0 / $627.3K
·
External
cardiology,
medical devices,
clinical trials,
cardiovascular surgery,
safety evaluation
A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults with Pulmonary Arterial Hypertension
Active
·
2023
·
$0 / $235.2K
·
External
pulmonary hypertension,
drug efficacy,
clinical trial,
safety
A Randomized, Doubleblind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Active
·
2023
·
$0 / $167.3K
·
External
pulmonary fibrosis,
inhaled treprostinil,
efficacy,
safety
Page 1 of 2
Previous page
Next page